The Lancet Infectious Diseases, 1473-3099

Journal

Publications

  1. 2019
  2. Accepted/In press
  3. Published

    Clinical utility of existing and second-generation interferon-γ release assays for diagnostic evaluation of tuberculosis: an observational cohort study

    Whitworth, H. S., Badhan, A., Boakye, A. A., Yemisi Takwoingi, Rees-Roberts, M., Christopher Partlett, Lambie, H., Innes, J., Cooke, G., Lipman, M., Conlon, C., Macallan, D., Chua, F., Post, F., Wiselka, M., Woltmann, G., Jon Deeks, Kon, O. M. & Lalvani, A., 1 Feb 2019, In : The Lancet Infectious Diseases. 19, 2, p. 193-202 10 p.

    Research output: Contribution to journalArticle

  4. 2018
  5. Published

    Prognostic value of interferon-γ release assays and tuberculin skin test in predicting the development of active tuberculosis (UK PREDICT TB): a prospective cohort study

    Abubakar, I., Drobniewski, F., Southern, J., Sitch, A., Jackson, C., Lipman, M., Deeks, J., Griffiths, C., Bothamley, G., Lynn, W., Burgess, H., Mann, B., Imran, A., Sridhar, S., Tsou, C-Y., Nikolayevskyy, V., Rees-Roberts, M., Whitworth, H., Kon, O. M., Haldar, P. & 7 othersKunst, H., Anderson, S., Hayward, A., Watson, J., Milburn, H., Lalvani, A. & PREDICT, Oct 2018, In : The Lancet Infectious Diseases. 18, 10, p. 1077-1087

    Research output: Contribution to journalArticle

  6. E-pub ahead of print
  7. 2017
  8. E-pub ahead of print

    Addressing antimicrobial resistance in the UK and Europe

    Laura Piddock & Wells, V., 10 Nov 2017, In : The Lancet Infectious Diseases.

    Research output: Contribution to journalComment/debate

  9. Published

    To the G20: incentivising antibacterial research and development

    Årdal, C., Baraldi, E., Ciabuschi, F., Outterson, K., Rex, J. H., Laura Piddock, Findlay, D. & DRIVE-AB Steering Committee, Aug 2017, In : The Lancet Infectious Diseases. 17, 8, p. 799-801

    Research output: Contribution to journalComment/debate

  10. 2016
  11. Published

    Risk of reproductive complications following chlamydia testing

    Malcolm Price, Nov 2016, In : The Lancet Infectious Diseases. 16, 11, p. 1223-1224

    Research output: Contribution to journalComment/debate

  12. Published

    Reflecting on the final report of the O'Neill Review on Antimicrobial Resistance.

    Laura Piddock, Jul 2016, In : The Lancet Infectious Diseases. p. 767-768 1 p.

    Research output: Contribution to journalLetter

  13. E-pub ahead of print

    Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial

    Manns, M., Samuel, D., Gane, E. J., Mutimer, D., McCaughan, G., Buti, M., Prieto, M., Calleja, J. L., Peck-Radosavljevic, M., Müllhaupt, B., Agarwal, K., Angus, P., Yoshida, E. M., Colombo, M., Rizzetto, M., Dvory-Sobol, H., Denning, J., Arterburn, S., Pang, P. S., Brainard, D. & 6 othersMcHutchison, J. G., Dufour, J-F., Van Vlierberghe, H., van Hoek, B., Forns, X. & SOLAR-2 investigators, 18 Feb 2016, In : The Lancet Infectious Diseases.

    Research output: Contribution to journalArticle

  14. Published

    Alternatives to antibiotics – a pipeline portfolio review

    Czaplewski, L., Bax, R., Clokie, M., Dawson, M., Fairhead, H., Fischetti, V. A., Foster, S., Gilmore, B. F., Hancock, R. E. W., Harper, D., Henderson, I. R., Hilpert, K., Jones, B. V., Kadioglu, A., Knowles, D., Ólafsdóttir, S., Payne, D., Projan, S., Shaunak, S., Silverman, J. & 4 othersChris Thomas, Trust, T. J., Warn, P. & Rex, J. H., Feb 2016, In : The Lancet Infectious Diseases. 16, 2, p. 239–251 13 p.

    Research output: Contribution to journalArticle

Previous 1 2 3 Next